1. Home
  2. BIAF vs GIPR Comparison

BIAF vs GIPR Comparison

Compare BIAF & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GIPR
  • Stock Information
  • Founded
  • BIAF 2014
  • GIPR 2015
  • Country
  • BIAF United States
  • GIPR United States
  • Employees
  • BIAF N/A
  • GIPR N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GIPR Real Estate Investment Trusts
  • Sector
  • BIAF Health Care
  • GIPR Real Estate
  • Exchange
  • BIAF Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • BIAF 6.7M
  • GIPR 6.4M
  • IPO Year
  • BIAF 2022
  • GIPR 2021
  • Fundamental
  • Price
  • BIAF $1.59
  • GIPR $1.00
  • Analyst Decision
  • BIAF Hold
  • GIPR
  • Analyst Count
  • BIAF 1
  • GIPR 0
  • Target Price
  • BIAF N/A
  • GIPR N/A
  • AVG Volume (30 Days)
  • BIAF 175.0K
  • GIPR 155.9K
  • Earning Date
  • BIAF 11-14-2025
  • GIPR 11-28-2025
  • Dividend Yield
  • BIAF N/A
  • GIPR N/A
  • EPS Growth
  • BIAF N/A
  • GIPR N/A
  • EPS
  • BIAF N/A
  • GIPR N/A
  • Revenue
  • BIAF $6,776,739.00
  • GIPR $9,953,920.00
  • Revenue This Year
  • BIAF N/A
  • GIPR $1.12
  • Revenue Next Year
  • BIAF $20.04
  • GIPR $0.52
  • P/E Ratio
  • BIAF N/A
  • GIPR N/A
  • Revenue Growth
  • BIAF N/A
  • GIPR N/A
  • 52 Week Low
  • BIAF $1.52
  • GIPR $0.78
  • 52 Week High
  • BIAF $46.53
  • GIPR $2.06
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 34.93
  • GIPR 37.58
  • Support Level
  • BIAF $1.91
  • GIPR $1.24
  • Resistance Level
  • BIAF $2.25
  • GIPR $1.13
  • Average True Range (ATR)
  • BIAF 0.20
  • GIPR 0.10
  • MACD
  • BIAF -0.06
  • GIPR -0.04
  • Stochastic Oscillator
  • BIAF 6.54
  • GIPR 1.03

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: